{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:23:54Z","timestamp":1793939034716,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH116043"],"award-info":[{"award-number":["MH116043"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS120987"],"award-info":[{"award-number":["NS120987"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","id":[{"id":"https:\/\/ror.org\/01s5ya894","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","id":[{"id":"https:\/\/ror.org\/04xeg9z08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Terazosin is an \u03b1\n                    <jats:sub>1<\/jats:sub>\n                    -adrenergic receptor antagonist that enhances glycolysis and increases cellular ATP by binding to the enzyme phosphoglycerate kinase 1 (PGK1). Recent work has shown that terazosin is protective against motor dysfunction in rodent models of Parkinson\u2019s disease (PD) and is associated with slowed motor symptom progression in PD patients. However, PD is also characterized by profound cognitive symptoms. We tested the hypothesis that terazosin protects against cognitive symptoms associated with PD. We report two main results. First, in rodents with ventral tegmental area (VTA) dopamine depletion modeling aspects of PD-related cognitive dysfunction, we found that terazosin preserved cognitive function. Second, we found that after matching for demographics, comorbidities, and disease duration, PD patients newly started on terazosin, alfuzosin, or doxazosin had a lower hazard of being diagnosed with dementia compared to tamsulosin, an \u03b1\n                    <jats:sub>1<\/jats:sub>\n                    -adrenergic receptor antagonist that does not enhance glycolysis. Together, these findings suggest that in addition to slowing motor symptom progression, glycolysis-enhancing drugs protect against cognitive symptoms of PD.\n                  <\/jats:p>","DOI":"10.1038\/s41531-023-00477-1","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T14:04:07Z","timestamp":1677765847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Glycolysis-enhancing \u03b11-adrenergic antagonists modify cognitive symptoms related to Parkinson\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0488-1792","authenticated-orcid":false,"given":"Matthew A.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ervina E.","family":"Tabakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina M.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob E.","family":"Simmering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0427-0003","authenticated-orcid":false,"given":"Nandakumar S.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"477_CR1","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease. Neuron 39, 889\u2013909 (2003).","journal-title":"Neuron"},{"key":"477_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1517\/14728222.2012.664135","volume":"16","author":"U Saxena","year":"2012","unstructured":"Saxena, U. Bioenergetics failure in neurodegenerative diseases: back to the future. Expert Opin. Ther. Targets 16, 351\u2013354 (2012).","journal-title":"Expert Opin. Ther. Targets"},{"key":"477_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wsbm.107","volume":"3","author":"P Wellstead","year":"2011","unstructured":"Wellstead, P. & Cloutier, M. An energy systems approach to Parkinson\u2019s disease. WIREs Syst. Biol. Med. 3, 1\u20136 (2011).","journal-title":"WIREs Syst. Biol. Med."},{"key":"477_CR4","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","volume":"129","author":"R Cai","year":"2019","unstructured":"Cai, R. et al. Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases. J. Clin. Invest. 129, 4539\u20134549 (2019).","journal-title":"J. Clin. Invest."},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2021.11.022","volume":"94","author":"JL Schultz","year":"2022","unstructured":"Schultz, J. L. et al. A pilot to assess target engagement of terazosin in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 94, 79\u201383 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"477_CR6","doi-asserted-by":"publisher","first-page":"e145112","DOI":"10.1172\/JCI145112","volume":"131","author":"R Sasane","year":"2021","unstructured":"Sasane, R. et al. Parkinson disease among patients treated for benign prostatic hyperplasia with \u03b11 adrenergic receptor antagonists. J. Clin. Invest. 131, e145112 (2021).","journal-title":"J. Clin. Invest."},{"key":"477_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamaneurol.2020.5157","volume":"78","author":"JE Simmering","year":"2021","unstructured":"Simmering, J. E., Welsh, M. J., Liu, L., Narayanan, N. S. & Potteg\u00e5rd, A. Association of glycolysis-enhancing \u03b1-1 blockers with risk of developing Parkinson disease. JAMA Neurol. 78, 407 (2021).","journal-title":"JAMA Neurol."},{"key":"477_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-021-00158-x","volume":"7","author":"A Singh","year":"2021","unstructured":"Singh, A. et al. Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson\u2019s disease. Npj Park. Dis. 7, 14 (2021).","journal-title":"Npj Park. Dis."},{"key":"477_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1152\/jn.00412.2015","volume":"114","author":"KL Parker","year":"2015","unstructured":"Parker, K. L., Chen, K.-H., Kingyon, J. R., Cavanagh, J. F. & Narayanan, N. S. Medial frontal \u223c 4\u2009Hz activity in humans and rodents is attenuated in PD patients and in rodents with cortical dopamine depletion. J. Neurophysiol. 114, 1310\u20131320 (2015).","journal-title":"J. Neurophysiol."},{"key":"477_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrn1764","volume":"6","author":"CV Buhusi","year":"2005","unstructured":"Buhusi, C. V. & Meck, W. H. What makes us tick? Functional and neural mechanisms of interval timing. Nat. Rev. Neurosci. 6, 755\u2013765 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"477_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cub.2016.11.029","volume":"27","author":"Y-C Kim","year":"2017","unstructured":"Kim, Y.-C. et al. Optogenetic stimulation of frontal D1 neurons compensates for impaired temporal control of action in dopamine-depleted mice. Curr. Biol. 27, 39\u201347 (2017).","journal-title":"Curr. Biol."},{"key":"477_CR12","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/cercor\/bhy083","volume":"29","author":"Y-C Kim","year":"2019","unstructured":"Kim, Y.-C. & Narayanan, N. S. Prefrontal D1 dopamine-receptor neurons and delta resonance in interval timing. Cereb. Cortex 29, 2051\u20132060 (2019).","journal-title":"Cereb. Cortex"},{"key":"477_CR13","doi-asserted-by":"publisher","first-page":"20726","DOI":"10.1073\/pnas.1211258109","volume":"109","author":"NS Narayanan","year":"2012","unstructured":"Narayanan, N. S., Land, B. B., Solder, J. E., Deisseroth, K. & DiLeone, R. J. Prefrontal D1 dopamine signaling is required for temporal control. Proc. Natl Acad. Sci. USA 109, 20726\u201320731 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"477_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1601-183X.2007.00348.x","volume":"7","author":"F Balci","year":"2008","unstructured":"Balci, F. et al. Interval timing in genetically modified mice: a simple paradigm. Genes Brain Behav. 7, 373\u2013384 (2008).","journal-title":"Genes Brain Behav."},{"key":"477_CR15","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1111\/ejn.15344","volume":"54","author":"RA Bruce","year":"2021","unstructured":"Bruce, R. A. et al. Experience-related enhancements in striatal temporal encoding. Eur. J. Neurosci. 54, 5063\u20135074 (2021).","journal-title":"Eur. J. Neurosci."},{"key":"477_CR16","doi-asserted-by":"publisher","first-page":"113967","DOI":"10.1016\/j.bbr.2022.113967","volume":"432","author":"T Larson","year":"2022","unstructured":"Larson, T. et al. Mice expressing P301S mutant human tau have deficits in interval timing. Behav. Brain Res. 432, 113967 (2022).","journal-title":"Behav. Brain Res."},{"key":"477_CR17","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jnr.24418","volume":"97","author":"E G\u00fcr","year":"2019","unstructured":"G\u00fcr, E. et al. Interval timing is disrupted in female 5xFAD mice: an indication of altered memory processes. J. Neurosci. Res. 97, 817\u2013827 (2019).","journal-title":"J. Neurosci. Res."},{"key":"477_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.baga.2015.06.001","volume":"5","author":"SL Alberico","year":"2015","unstructured":"Alberico, S. L., Cassell, M. D. & Narayanan, N. S. The vulnerable ventral tegmental area in Parkinson\u2019s disease. Basal Ganglia 5, 51\u201355 (2015).","journal-title":"Basal Ganglia"},{"key":"477_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1037\/bne0000528","volume":"136","author":"CV Buhusi","year":"2022","unstructured":"Buhusi, C. V., Matthews, A. R. & Buhusi, M. mPFC catecholamines modulate attentional capture by appetitive distracters and attention to time in a peak-interval procedure in rats. Behav. Neurosci. 136, 418\u2013429 (2022).","journal-title":"Behav. Neurosci."},{"key":"477_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fnint.2012.00111","volume":"6","author":"AR Matthews","year":"2012","unstructured":"Matthews, A. R. Dissociation of the role of the prelimbic cortex in interval timing and resource allocation: beneficial effect of norepinephrine and dopamine reuptake inhibitor nomifensine on anxiety-inducing distraction. Front. Integr. Neurosci. 6, 111 (2012).","journal-title":"Front. Integr. Neurosci."},{"key":"477_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2020.02.021","volume":"90","author":"E G\u00fcr","year":"2020","unstructured":"G\u00fcr, E., Duyan, Y. A., Arkan, S., Karson, A. & Balc\u0131, F. Interval timing deficits and their neurobiological correlates in aging mice. Neurobiol. Aging 90, 33\u201342 (2020).","journal-title":"Neurobiol. Aging"},{"key":"477_CR22","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1002\/mds.28712","volume":"36","author":"P Gros","year":"2021","unstructured":"Gros, P. et al. Exposure to phosphoglycerate kinase 1 activators and incidence of Parkinson\u2019s disease. Mov. Disord. Off. J. Mov. Disord. Soc. 36, 2419\u20132425 (2021).","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"477_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1518316113","volume":"113","author":"T Tosun","year":"2016","unstructured":"Tosun, T., G\u00fcr, E. & Balc\u0131, F. Mice plan decision strategies based on previously learned time intervals, locations, and probabilities. Proc. Natl Acad. Sci. USA 113, 787\u2013792 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"477_CR24","doi-asserted-by":"publisher","first-page":"tgaa058","DOI":"10.1093\/texcom\/tgaa058","volume":"1","author":"E Emmons","year":"2020","unstructured":"Emmons, E. et al. Temporal learning among prefrontal and striatal ensembles. Cereb. Cortex Commun. 1, tgaa058 (2020).","journal-title":"Cereb. Cortex Commun."},{"key":"477_CR25","doi-asserted-by":"publisher","unstructured":"Thiele, S. L., Warre, R. & Nash, J. E. Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson\u2019s disease. J. Vis. Exp. JoVE https:\/\/doi.org\/10.3791\/3234 (2012).","DOI":"10.3791\/3234"},{"key":"477_CR26","doi-asserted-by":"crossref","unstructured":"Torres, E. M. & Dunnett, S. B. Animal Models of Movement Disorders: Volume I (eds Lane, E. L. & Dunnett, S. B.) 267\u2013279 (Humana Press, 2012).","DOI":"10.1007\/978-1-61779-298-4_13"},{"key":"477_CR27","first-page":"525","volume":"55","author":"ML Nicolaus","year":"2016","unstructured":"Nicolaus, M. L., Bergdall, V. K., Davis, I. C. & Hickman-Davis, J. M. Effect of ventilated caging on water intake and loss in 4 strains of laboratory mice. J. Am. Assoc. Lab. Anim. Sci. JAALAS 55, 525\u2013533 (2016).","journal-title":"J. Am. Assoc. Lab. Anim. Sci. JAALAS"},{"key":"477_CR28","unstructured":"Franklin, K. B. J. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates. (Elsevier Academic Press, 2008)."},{"key":"477_CR29","unstructured":"Protections (OHRP), O. for H. R. Human Subject Regulations Decision Charts: 2018 Requirements. HHS.gov https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/decision-charts-2018\/index.html (2010)."},{"key":"477_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","volume":"2","author":"JL Lund","year":"2015","unstructured":"Lund, J. L., Richardson, D. B. & St\u00fcrmer, T. The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr. Epidemiol. Rep. 2, 221\u2013228 (2015).","journal-title":"Curr. Epidemiol. Rep."},{"key":"477_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/pds.4708","volume":"29","author":"MH Secrest","year":"2020","unstructured":"Secrest, M. H. et al. Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiol. Drug Saf. 29, 26\u201334 (2020).","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00477-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00477-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T14:05:24Z","timestamp":1677765924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00477-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00477-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.01.22277111","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"1 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}